Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)

NCT04886284 is registered in ClinicalTrials.gov with Todd C. Lee MD MPH FIDSA as lead sponsor.

NCT NCT04886284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04886284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)
Lead sponsor
Todd C. Lee MD MPH FIDSA
Phase
Phase 2
Overall status
Recruiting
Start date
May 20, 2024
Completion date
July 31, 2027
Enrollment
60 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcal sepsis, staphylococcus aureus bacteremia, staphylococcus aureus endocarditis, staphylococcus aureus septicemia